Community-based treatment of onchocerciasis with ivermectin: Safety, efficacy, and acceptability of yearly treatment

Michel Pacqué, Beatriz Munoz, Bruce M. Greene, Hugh R. Taylor

Research output: Contribution to journalArticle

Abstract

The safety, acceptability, and efficacy of ivermectin during community-based mass treatment of onchocerciasis was assessed. Ivermectin was distributed three times, 1 year apart, to the population of a rubber plantation (14,000 people) in Liberia where >80% of adults have Onchocerca volvulus infection. In a sample of adults, the microfilarial density was reduced by 84% after 2 years of treatment. Acceptance was as high as 98% during the third year. Adverse reactions occurred in 6-13 in 1000 people after first treatment and in only 3-4 in 1000 receiving their second or third annual dose of ivermectin; severe adverse reactions were not seen. These data show that community-based treatment with ivermectin is safe, well accepted, and effective in reducing microfilarial loads and suggest that ivermectin is the first practical drug suitable for mass treatment campaigns to control human onchocerciasis.

Original languageEnglish (US)
Pages (from-to)381-385
Number of pages5
JournalJournal of Infectious Diseases
Volume163
Issue number2
DOIs
StatePublished - 1991

Fingerprint

Onchocerciasis
Ivermectin
Safety
Liberia
Onchocerca volvulus
Rubber
Infection
Pharmaceutical Preparations
Population

ASJC Scopus subject areas

  • Infectious Diseases
  • Immunology and Allergy
  • Immunology
  • Public Health, Environmental and Occupational Health

Cite this

Community-based treatment of onchocerciasis with ivermectin : Safety, efficacy, and acceptability of yearly treatment. / Pacqué, Michel; Munoz, Beatriz; Greene, Bruce M.; Taylor, Hugh R.

In: Journal of Infectious Diseases, Vol. 163, No. 2, 1991, p. 381-385.

Research output: Contribution to journalArticle

@article{c6930a59997e4649a79888e8868d44b6,
title = "Community-based treatment of onchocerciasis with ivermectin: Safety, efficacy, and acceptability of yearly treatment",
abstract = "The safety, acceptability, and efficacy of ivermectin during community-based mass treatment of onchocerciasis was assessed. Ivermectin was distributed three times, 1 year apart, to the population of a rubber plantation (14,000 people) in Liberia where >80{\%} of adults have Onchocerca volvulus infection. In a sample of adults, the microfilarial density was reduced by 84{\%} after 2 years of treatment. Acceptance was as high as 98{\%} during the third year. Adverse reactions occurred in 6-13 in 1000 people after first treatment and in only 3-4 in 1000 receiving their second or third annual dose of ivermectin; severe adverse reactions were not seen. These data show that community-based treatment with ivermectin is safe, well accepted, and effective in reducing microfilarial loads and suggest that ivermectin is the first practical drug suitable for mass treatment campaigns to control human onchocerciasis.",
author = "Michel Pacqu{\'e} and Beatriz Munoz and Greene, {Bruce M.} and Taylor, {Hugh R.}",
year = "1991",
doi = "10.1093/infdis/163.2.381",
language = "English (US)",
volume = "163",
pages = "381--385",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Community-based treatment of onchocerciasis with ivermectin

T2 - Safety, efficacy, and acceptability of yearly treatment

AU - Pacqué, Michel

AU - Munoz, Beatriz

AU - Greene, Bruce M.

AU - Taylor, Hugh R.

PY - 1991

Y1 - 1991

N2 - The safety, acceptability, and efficacy of ivermectin during community-based mass treatment of onchocerciasis was assessed. Ivermectin was distributed three times, 1 year apart, to the population of a rubber plantation (14,000 people) in Liberia where >80% of adults have Onchocerca volvulus infection. In a sample of adults, the microfilarial density was reduced by 84% after 2 years of treatment. Acceptance was as high as 98% during the third year. Adverse reactions occurred in 6-13 in 1000 people after first treatment and in only 3-4 in 1000 receiving their second or third annual dose of ivermectin; severe adverse reactions were not seen. These data show that community-based treatment with ivermectin is safe, well accepted, and effective in reducing microfilarial loads and suggest that ivermectin is the first practical drug suitable for mass treatment campaigns to control human onchocerciasis.

AB - The safety, acceptability, and efficacy of ivermectin during community-based mass treatment of onchocerciasis was assessed. Ivermectin was distributed three times, 1 year apart, to the population of a rubber plantation (14,000 people) in Liberia where >80% of adults have Onchocerca volvulus infection. In a sample of adults, the microfilarial density was reduced by 84% after 2 years of treatment. Acceptance was as high as 98% during the third year. Adverse reactions occurred in 6-13 in 1000 people after first treatment and in only 3-4 in 1000 receiving their second or third annual dose of ivermectin; severe adverse reactions were not seen. These data show that community-based treatment with ivermectin is safe, well accepted, and effective in reducing microfilarial loads and suggest that ivermectin is the first practical drug suitable for mass treatment campaigns to control human onchocerciasis.

UR - http://www.scopus.com/inward/record.url?scp=0026011670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026011670&partnerID=8YFLogxK

U2 - 10.1093/infdis/163.2.381

DO - 10.1093/infdis/163.2.381

M3 - Article

C2 - 1988522

AN - SCOPUS:0026011670

VL - 163

SP - 381

EP - 385

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 2

ER -